profit slide india dr reddy profit indian drugmaker dr reddy fell research cost rise sale flag firm say profit rupee three month december sale fell rupee dr reddy build reputation produce generic version pharmaceutical product competition intensify firm company short new product launch recent annoucement december exclusive marketing right generic version famous prozac maker eli lilly also lose key court case march ban sell version pfizer popular hypertension drug norvasc u research development new drug continue apace r spending rise rupee key cause decrease profit alongside fall sale patent number product due run near future represent opportunity dr reddy whose share list new york indian generic manufacturer sale dr reddy generic business fell rupee another staple firm business sale ingredient drug also perform poorly sale previous year rupee face strong competition home u europe dr reddy indian competitor gather strength although face heavy competitive pressure